,reactionmeddraversionpt,reactionmeddrapt,reactionoutcome,safetyreportid
0,22.0,Death,5,16531516
0,22.1,Death,5,16531524
0,22.0,Neuropathy peripheral,6,16531534
0,22.0,Diarrhoea,,16531587
1,22.0,Diarrhoea,1,16531587
2,22.0,Diarrhoea,1,16531587
3,22.0,Diarrhoea,1,16531587
0,22.1,Neutropenia,1,16531626
1,22.1,Anaemia,1,16531626
2,22.1,Interstitial lung disease,2,16531626
0,22.0,Compression fracture,6,16531639
0,22.0,Infusion related reaction,6,16531643
0,22.1,Cholangitis sclerosing,5,16531649
0,22.0,Renal disorder,6,16531657
1,22.0,Hypertension,6,16531657
0,22.0,Diarrhoea,6,16531660
1,22.0,Ulcer,6,16531660
0,22.0,Bone marrow transplant rejection,2,16531714
1,22.0,Bone marrow failure,2,16531714
0,22.0,Pancytopenia,1,16531720
0,22.0,Skin exfoliation,,16531725
0,22.0,Pleural effusion,6,16531734
1,22.0,Atrial fibrillation,6,16531734
2,22.0,Pericardial effusion,6,16531734
3,22.0,Urinary tract infection enterococcal,6,16531734
4,22.0,Autoimmune pericarditis,6,16531734
0,22.0,Neoplasm malignant,6,16531758
1,22.0,Terminal state,6,16531758
0,22.0,Hypotension,1,16531767
1,22.0,Seizure,1,16531767
0,22.0,Blood urine present,3,16531786
1,22.0,Product availability issue,6,16531786
2,22.0,Product dose omission,6,16531786
3,22.0,Intentional product use issue,6,16531786
0,22.0,Disease progression,6,16531787
0,22.0,Disease progression,6,16531803
0,22.1,Therapy cessation,6,16531834
1,22.1,Dementia,6,16531834
2,22.1,Product availability issue,6,16531834
0,22.0,Metastases to liver,6,16531849
1,22.0,Rash,2,16531849
2,22.0,Metastases to bone,6,16531849
0,22.0,Haematotoxicity,6,16531865
1,22.0,Hepatotoxicity,6,16531865
0,22.0,Hospitalisation,6,16531886
0,22.0,Drug ineffective,6,16531891
1,22.0,Malignant neoplasm progression,6,16531891
0,22.0,Colon cancer metastatic,5,16531918
0,22.1,Uterine haemorrhage,1,16531927
1,22.1,Anaemia,1,16531927
2,22.1,Adenomyosis,1,16531927
0,22.0,Metastases to lymph nodes,6,16531939
1,22.0,Renal cancer,5,16531939
2,22.0,General physical condition abnormal,6,16531939
3,22.0,Condition aggravated,6,16531939
4,22.0,Mobility decreased,6,16531939
5,22.0,Acute kidney injury,3,16531939
6,22.0,Lethargy,6,16531939
7,22.0,Diarrhoea,1,16531939
8,22.0,Confusional state,6,16531939
9,22.0,Infection,6,16531939
10,22.0,Vomiting,1,16531939
11,22.0,Chronic kidney disease,6,16531939
12,22.0,Malignant neoplasm progression,5,16531939
13,22.0,Myocardial infarction,6,16531939
14,22.0,Haemoglobin decreased,6,16531939
15,22.0,Pleural effusion,6,16531939
16,22.0,Blood pressure decreased,6,16531939
17,22.0,Vena cava thrombosis,6,16531939
18,22.0,Peripheral swelling,6,16531939
0,22.0,Death,5,16531951
0,22.1,Alopecia,3,16531955
1,22.1,Bipolar II disorder,6,16531955
2,22.1,Madarosis,3,16531955
3,22.1,Hair colour changes,3,16531955
4,22.1,Hair disorder,3,16531955
5,22.1,Depression,6,16531955
6,22.1,Hair texture abnormal,3,16531955
0,22.1,Chills,4,16531959
1,22.1,Diarrhoea,1,16531959
2,22.1,Peripheral artery thrombosis,6,16531959
3,22.1,Hypokalaemia,2,16531959
4,22.1,Hypotension,1,16531959
5,22.1,Albuminuria,1,16531959
6,22.1,Hypomagnesaemia,1,16531959
7,22.1,Deep vein thrombosis,3,16531959
8,22.1,Diarrhoea,2,16531959
9,22.1,Anaemia,1,16531959
10,22.1,Dehydration,2,16531959
11,22.1,Neutropenic sepsis,6,16531959
12,22.1,Blood pressure increased,1,16531959
13,22.1,Ocular hyperaemia,4,16531959
0,22.0,Ovarian cancer recurrent,5,16531973
0,22.0,Bundle branch block left,2,16532022
1,22.0,Mitral valve incompetence,2,16532022
2,22.0,Congestive cardiomyopathy,2,16532022
3,22.0,Left ventricular dysfunction,2,16532022
4,22.0,Coronary artery disease,2,16532022
5,22.0,Cardiotoxicity,2,16532022
6,22.0,Cardiac dysfunction,2,16532022
7,22.0,Cardiac failure chronic,2,16532022
0,22.0,Pyrexia,1,16532031
0,22.0,Intestinal obstruction,1,16532034
1,22.0,Depressive symptom,1,16532034
0,22.1,Intestinal obstruction,6,16532041
0,22.0,Hypertension,6,16532043
0,22.0,Aspartate aminotransferase increased,6,16532048
1,22.0,Off label use,3,16532048
2,22.0,Alanine aminotransferase increased,6,16532048
0,22.0,Anaphylactic reaction,1,16532073
0,22.0,Blood pressure increased,1,16532078
1,22.0,Infusion related reaction,1,16532078
0,22.0,Road traffic accident,6,16532083
1,22.0,Tendon rupture,3,16532083
2,22.0,Joint injury,3,16532083
0,22.0,Disease progression,6,16532099
0,22.0,Off label use,6,16532101
1,22.0,Intentional product use issue,6,16532101
2,22.0,Metastases to central nervous system,6,16532101
0,22.0,Migraine,6,16532116
1,22.0,Joint range of motion decreased,6,16532116
2,22.0,Metastasis,6,16532116
0,22.0,Haemorrhage,6,16532135
0,22.1,Chronic obstructive pulmonary disease,3,16532139
0,22.1,Neoplasm progression,6,16532141
0,22.0,Sepsis,5,16532156
1,22.0,Disseminated intravascular coagulation,3,16532156
2,22.0,Septic shock,5,16532156
3,22.0,Respiratory failure,5,16532156
4,22.0,Device related infection,5,16532156
5,22.0,Acute kidney injury,5,16532156
6,22.0,Interstitial lung disease,3,16532156
0,22.0,Abdominal pain upper,,16532157
1,22.0,Drug intolerance,,16532157
2,22.0,Abdominal pain,,16532157
3,22.0,Vomiting,,16532157
4,22.0,Dizziness,,16532157
5,22.0,Arrhythmia,,16532157
0,22.1,Blood urine present,1,16532160
1,22.1,Abdominal pain,6,16532160
2,22.1,Toothache,1,16532160
3,22.1,Condition aggravated,1,16532160
4,22.1,Abdominal distension,1,16532160
5,22.1,Nephrolithiasis,1,16532160
6,22.1,Flatulence,1,16532160
7,22.1,Tongue erythema,3,16532160
8,22.1,Urethral obstruction,1,16532160
9,22.1,Blister,6,16532160
10,22.1,Oral pain,1,16532160
11,22.1,Calculus urethral,1,16532160
12,22.1,Feeding disorder,1,16532160
13,22.1,Dysuria,1,16532160
14,22.1,Malaise,3,16532160
15,22.1,Retching,3,16532160
16,22.1,Weight decreased,3,16532160
17,22.1,Dry skin,6,16532160
18,22.1,Gait disturbance,1,16532160
19,22.1,Chromaturia,3,16532160
20,22.1,Renal pain,3,16532160
21,22.1,Plantar erythema,1,16532160
22,22.1,Glossitis,3,16532160
23,22.1,Condition aggravated,3,16532160
24,22.1,Constipation,1,16532160
25,22.1,Glossodynia,1,16532160
26,22.1,Pruritus,6,16532160
27,22.1,Mouth injury,3,16532160
0,22.0,Blood pressure increased,2,16532174
0,22.0,Interstitial lung disease,1,16532225
0,22.1,Bone marrow failure,6,16532233
1,22.1,Pyrexia,6,16532233
2,22.1,Bone pain,6,16532233
3,22.1,Neutropenia,6,16532233
4,22.1,Fatigue,6,16532233
5,22.1,White blood cell count decreased,6,16532233
6,22.1,Leukopenia,6,16532233
7,22.1,Alopecia,3,16532233
8,22.1,Insomnia,6,16532233
9,22.1,Back pain,6,16532233
0,22.0,Febrile neutropenia,6,16532235
0,22.0,Hepatic function abnormal,2,16532248
0,22.0,Drug hypersensitivity,6,16532252
0,22.0,Depression suicidal,3,16532266
0,22.0,Paraesthesia,4,16532270
1,22.0,Sensation of foreign body,4,16532270
2,22.0,Dizziness,4,16532270
3,22.0,Dyspnoea,4,16532270
0,22.1,Cardiovascular disorder,6,16532271
0,22.0,Therapy cessation,,16532311
1,22.0,Gastric operation,,16532311
0,22.0,Toxicity to various agents,6,16532316
0,22.1,Intestinal obstruction,6,16532319
1,22.1,Product dose omission,6,16532319
2,22.1,Bronchitis,6,16532319
3,22.1,Gingival pain,6,16532319
4,22.1,Alopecia,6,16532319
5,22.1,Sneezing,6,16532319
6,22.1,Nasal pruritus,6,16532319
7,22.1,Tooth disorder,6,16532319
0,22.0,Proteinuria,6,16532321
0,22.0,Toxicity to various agents,6,16532324
0,22.0,Wound dehiscence,1,16532325
0,22.0,Hypertension,3,16532327
1,22.0,Neutrophil count decreased,3,16532327
2,22.0,Blood creatinine increased,3,16532327
3,22.0,Blood sodium decreased,3,16532327
4,22.0,Red cell distribution width increased,3,16532327
5,22.0,Blood test abnormal,3,16532327
6,22.0,White blood cell count decreased,3,16532327
0,22.0,Arrhythmia,6,16532332
0,22.0,Fatigue,6,16532339
1,22.0,Proteinuria,6,16532339
2,22.0,Neutropenia,6,16532339
0,22.0,Thrombophlebitis,6,16532343
0,22.0,Neoplasm progression,6,16532344
0,22.0,White blood cell count decreased,6,16532346
1,22.0,Thrombosis,6,16532346
0,22.0,Neutropenia,6,16532350
1,22.0,Thrombophlebitis,6,16532350
0,22.0,Hypertension,6,16532351
0,22.0,Skin disorder,6,16532352
1,22.0,Pruritus,6,16532352
0,22.0,Toxicity to various agents,6,16532354
0,22.0,White blood cell count decreased,6,16532363
1,22.0,Fatigue,6,16532363
2,22.0,Nausea,1,16532363
3,22.0,Stomatitis,2,16532363
4,22.0,Asthenia,6,16532363
5,22.0,Malaise,6,16532363
6,22.0,Platelet count decreased,6,16532363
7,22.0,Urinary tract infection,6,16532363
0,22.0,Arthralgia,6,16532366
1,22.0,Arthritis,6,16532366
0,22.0,Transient ischaemic attack,6,16532380
0,22.0,Adenocarcinoma,5,16532382
0,22.0,Vomiting,6,16532388
1,22.0,Gait disturbance,6,16532388
2,22.0,Bladder pain,6,16532388
3,22.0,Bedridden,6,16532388
4,22.0,Nausea,6,16532388
5,22.0,Dysuria,6,16532388
6,22.0,Micturition urgency,6,16532388
7,22.0,Urinary tract infection,6,16532388
0,22.0,Fracture,6,16532411
0,22.0,Nausea,1,16532417
1,22.0,Weight decreased,3,16532417
2,22.0,Haemoptysis,3,16532417
3,22.0,Feeling abnormal,3,16532417
4,22.0,Back pain,3,16532417
5,22.0,Dyspnoea,6,16532417
6,22.0,Decreased appetite,3,16532417
7,22.0,Nodule,3,16532417
8,22.0,Scar,2,16532417
0,22.0,Hospitalisation,6,16532421
1,22.0,Weight decreased,2,16532421
2,22.0,Polyarthritis,2,16532421
0,22.0,Osteonecrosis of jaw,,16532431
0,22.0,Rash,6,16532468
1,22.0,Hypothyroidism,6,16532468
2,22.0,Neuropathy peripheral,6,16532468
3,22.0,Nausea,6,16532468
0,22.1,Diabetes mellitus,2,16532470
1,22.1,IgA nephropathy,3,16532470
2,22.1,Pneumonia,1,16532470
0,22.1,Diarrhoea,1,16532491
1,22.1,Atrial fibrillation,6,16532491
2,22.1,Dry skin,6,16532491
3,22.1,Ventricular extrasystoles,1,16532491
4,22.1,Neutropenia,1,16532491
5,22.1,Atrial fibrillation,1,16532491
0,22.0,Ovarian cancer recurrent,6,16532515
0,22.1,Swelling face,3,16532516
1,22.1,Superinfection,2,16532516
2,22.1,Ejection fraction decreased,3,16532516
3,22.1,Abdominal pain lower,1,16532516
4,22.1,Nausea,3,16532516
5,22.1,Vomiting,3,16532516
6,22.1,Pain in extremity,3,16532516
7,22.1,Asthenia,3,16532516
8,22.1,Cellulitis,1,16532516
9,22.1,Headache,3,16532516
10,22.1,Abdominal pain,3,16532516
11,22.1,Mouth swelling,6,16532516
12,22.1,Cough,1,16532516
13,22.1,Lower respiratory tract infection,1,16532516
14,22.1,Urinary tract infection,3,16532516
0,22.0,Cardiac failure,5,16532521
1,22.0,Malignant neoplasm progression,5,16532521
0,22.0,Pelvic abscess,5,16532535
1,22.0,Death,5,16532535
0,22.0,Myocardial infarction,6,16532537
0,22.0,Neuropathy peripheral,5,16532540
0,22.0,Cerebrovascular accident,6,16532542
0,22.0,Fatigue,6,16532543
1,22.0,Pulmonary embolism,6,16532543
2,22.0,Nausea,6,16532543
0,22.0,Tooth abscess,3,16532546
0,22.1,Diarrhoea,1,16532548
1,22.1,Oropharyngeal pain,1,16532548
2,22.1,Vomiting,1,16532548
3,22.1,Pulmonary embolism,3,16532548
4,22.1,Dyspnoea,3,16532548
5,22.1,Dizziness,1,16532548
6,22.1,Back pain,1,16532548
7,22.1,Abdominal discomfort,3,16532548
8,22.1,Constipation,1,16532548
9,22.1,Asthenia,3,16532548
10,22.1,Urinary tract infection,1,16532548
11,22.1,Back pain,1,16532548
12,22.1,Chest pain,1,16532548
13,22.1,Headache,1,16532548
14,22.1,Hiccups,1,16532548
15,22.1,Nasal dryness,1,16532548
16,22.1,Polyneuropathy,3,16532548
17,22.1,Diarrhoea,1,16532548
18,22.1,Decreased appetite,6,16532548
19,22.1,Rhinorrhoea,1,16532548
20,22.1,Skin discolouration,1,16532548
21,22.1,Nausea,3,16532548
22,22.1,Pyrexia,1,16532548
23,22.1,Epistaxis,1,16532548
0,22.0,Disease progression,,16532566
0,22.1,Malignant neoplasm progression,5,16532593
1,22.1,Liver disorder,5,16532593
0,22.0,Pyrexia,1,16532641
1,22.0,Anaemia,1,16532641
2,22.0,Malaise,1,16532641
3,22.0,Renal disorder,1,16532641
0,22.0,Pain,1,16532653
1,22.0,Hyperhidrosis,1,16532653
2,22.0,Hypotension,1,16532653
3,22.0,Dyspnoea,1,16532653
4,22.0,Product use issue,1,16532653
0,22.1,Neoplasm progression,6,16532733
1,22.1,Alopecia,6,16532733
0,22.0,Lung disorder,1,16532751
1,22.0,Off label use,6,16532751
2,22.0,Malignant neoplasm progression,6,16532751
3,22.0,Pleural effusion,6,16532751
0,22.0,Jaw disorder,6,16532764
0,22.1,Interstitial lung disease,1,16532768
1,22.1,Interstitial lung disease,5,16532768
2,22.1,Malignant neoplasm progression,5,16532768
0,22.0,Neutrophil count decreased,3,16532805
1,22.0,Hepatic function abnormal,1,16532805
0,22.0,Palmar-plantar erythrodysaesthesia syndrome,,16532833
0,22.1,Off label use,6,16532922
1,22.1,Gastrooesophageal reflux disease,1,16532922
2,22.1,Dry eye,1,16532922
3,22.1,Hypersensitivity,1,16532922
4,22.1,Dizziness,1,16532922
5,22.1,Hypokalaemia,1,16532922
6,22.1,Upper respiratory tract infection,1,16532922
7,22.1,Muscle spasms,1,16532922
8,22.1,Constipation,1,16532922
0,22.0,Gastrooesophageal reflux disease,6,16532963
1,22.0,Dyspepsia,6,16532963
2,22.0,Diarrhoea,6,16532963
3,22.0,Hypersensitivity,3,16532963
4,22.0,Hepatic enzyme increased,6,16532963
5,22.0,Vomiting,6,16532963
6,22.0,Abdominal pain,3,16532963
7,22.0,Nausea,6,16532963
8,22.0,Dyspnoea,6,16532963
0,22.0,Nausea,6,16532966
1,22.0,Dehydration,1,16532966
2,22.0,Vomiting,1,16532966
3,22.0,Asthenia,3,16532966
0,22.0,Meningoencephalitis herpetic,1,16533011
1,22.0,Neutropenia,1,16533011
0,22.0,Syncope,1,16533044
1,22.0,Syncope,6,16533044
2,22.0,Heart rate decreased,6,16533044
0,22.1,Platelet count decreased,6,16533048
1,22.1,Catheter site haemorrhage,6,16533048
2,22.1,Pyelonephritis,6,16533048
3,22.1,Febrile neutropenia,1,16533048
4,22.1,Neutrophil count decreased,6,16533048
5,22.1,Hyponatraemia,6,16533048
0,22.0,Hepatic function abnormal,2,16533093
0,22.0,Hypoaesthesia,6,16533183
1,22.0,White blood cell count decreased,2,16533183
2,22.0,Back pain,6,16533183
3,22.0,Pain in extremity,6,16533183
4,22.0,Fatigue,2,16533183
5,22.0,Peripheral swelling,6,16533183
0,22.0,Fatigue,6,16533204
1,22.0,Depressed mood,6,16533204
2,22.0,Back pain,6,16533204
3,22.0,Nausea,6,16533204
0,22.0,Unevaluable event,6,16533216
1,22.0,Neuropathy peripheral,3,16533216
2,22.0,Neuralgia,3,16533216
0,22.0,Disease progression,,16533363
0,22.0,Device occlusion,6,16533366
0,22.0,Infected skin ulcer,6,16533389
1,22.0,Skin necrosis,6,16533389
2,22.0,Skin ulcer,6,16533389
0,22.0,Premature delivery,6,16533416
1,22.0,Menopause,6,16533416
2,22.0,Maternal exposure during pregnancy,6,16533416
3,22.0,Nausea,6,16533416
4,22.0,Anaemia,6,16533416
5,22.0,Vomiting,6,16533416
0,22.1,Fatigue,6,16533421
1,22.1,Alopecia,3,16533421
2,22.1,Neuropathy peripheral,2,16533421
3,22.1,Neoplasm progression,6,16533421
0,22.0,Renal failure,,16533471
1,22.0,Vomiting,,16533471
2,22.0,Urinary tract infection,,16533471
3,22.0,Pyrexia,,16533471
4,22.0,Cognitive disorder,,16533471
5,22.0,Diarrhoea,,16533471
0,22.0,Immune-mediated adverse reaction,1,16533494
1,22.0,Immune-mediated enterocolitis,1,16533494
2,22.0,Rash,1,16533494
3,22.0,Myasthenia gravis,1,16533494
4,22.0,Pericarditis,1,16533494
0,22.0,Deep vein thrombosis,6,16533504
1,22.0,Neuropathy peripheral,6,16533504
2,22.0,Ascites,3,16533504
3,22.0,Condition aggravated,3,16533504
0,22.0,Bone marrow failure,6,16533517
1,22.0,Nausea,6,16533517
2,22.0,Vomiting,6,16533517
3,22.0,Cardiotoxicity,6,16533517
0,22.0,Delirium,3,16533548
0,22.0,Suffocation feeling,2,16533561
1,22.0,Back pain,2,16533561
0,22.0,Metastases to pelvis,6,16533569
0,22.1,Lymphoedema,6,16533571
1,22.1,Erythema,3,16533571
2,22.1,Hot flush,3,16533571
3,22.1,Hyperhidrosis,3,16533571
4,22.1,Metastasis,6,16533571
5,22.1,Pain of skin,3,16533571
6,22.1,Hyperaesthesia,3,16533571
7,22.1,Gait disturbance,3,16533571
8,22.1,Oedema,6,16533571
0,22.0,Off label use,6,16533583
1,22.0,Death,5,16533583
0,22.0,Renal vasculitis,2,16533603
1,22.0,Tubulointerstitial nephritis,2,16533603
0,22.0,Lung disorder,1,16533615
0,22.1,Liver injury,3,16533640
0,22.0,Hypoxia,2,16533650
1,22.0,Septic shock,2,16533650
2,22.0,Anaemia,2,16533650
3,22.0,Mental status changes,6,16533650
4,22.0,Pyrexia,2,16533650
5,22.0,Pneumonia,6,16533650
0,22.0,Metastasis,6,16533671
0,22.0,Decreased appetite,6,16533672
1,22.0,Metastases to liver,3,16533672
2,22.0,Malignant neoplasm progression,6,16533672
3,22.0,Drug ineffective,3,16533672
4,22.0,Food aversion,6,16533672
0,22.0,Diarrhoea,1,16533685
1,22.0,Intestinal obstruction,1,16533685
2,22.0,Proctitis,1,16533685
3,22.0,Abdominal pain,1,16533685
0,22.0,Pyrexia,6,16533716
1,22.0,Type I hypersensitivity,6,16533716
0,22.0,Dizziness,1,16533733
1,22.0,Breast mass,3,16533733
0,22.0,Pyrexia,6,16533739
1,22.0,Pancytopenia,3,16533739
2,22.0,Immune thrombocytopenic purpura,6,16533739
0,22.0,Bone marrow failure,1,16533746
0,22.0,Leukopenia,2,16533748
1,22.0,Neutropenia,2,16533748
0,22.1,Vomiting,1,16533754
1,22.1,Cerebral infarction,2,16533754
0,22.0,Neutrophil count decreased,2,16533872
0,22.0,Drug intolerance,6,16533873
1,22.0,Rash,2,16533873
2,22.0,Metastases to central nervous system,6,16533873
0,22.0,Malignant neoplasm progression,6,16533874
1,22.0,Therapy cessation,3,16533874
2,22.0,Urinary incontinence,1,16533874
3,22.0,Drug ineffective,6,16533874
4,22.0,Cystitis,1,16533874
5,22.0,Urinary tract infection,6,16533874
0,22.0,Platelet count decreased,1,16533881
1,22.0,Blood bilirubin increased,6,16533881
2,22.0,Mouth haemorrhage,6,16533881
0,22.1,Diarrhoea,1,16533901
1,22.1,Musculoskeletal chest pain,1,16533901
2,22.1,Anxiety,3,16533901
3,22.1,Faeces discoloured,6,16533901
4,22.1,Gastric ulcer,1,16533901
5,22.1,Abdominal pain upper,3,16533901
6,22.1,Pharyngeal ulceration,3,16533901
7,22.1,Vomiting,3,16533901
0,22.0,Hair growth abnormal,6,16533906
1,22.0,Alopecia,3,16533906
2,22.0,Trichorrhexis,6,16533906
0,22.1,Hyperthyroidism,1,16533938
1,22.1,Hypoalbuminaemia,3,16533938
2,22.1,Seizure,2,16533938
3,22.1,Hyponatraemia,2,16533938
4,22.1,Fulminant type 1 diabetes mellitus,3,16533938
0,22.0,Myocardial infarction,5,16533969
0,22.1,Renal impairment,1,16533986
1,22.1,Hypothyroidism,1,16533986
2,22.1,Silent thyroiditis,1,16533986
0,22.0,Bone marrow failure,1,16533992
0,22.0,Hypersensitivity,6,16534000
0,22.1,Pulmonary embolism,5,16534006
1,22.1,Febrile neutropenia,4,16534006
2,22.1,Colitis ischaemic,4,16534006
0,22.0,Autoimmune haemolytic anaemia,6,16534017
0,22.0,Ejection fraction decreased,6,16534030
0,22.0,Vomiting,,16534039
1,22.0,Nausea,,16534039
0,22.0,Neoplasm progression,5,16534123
0,22.0,Ophthalmoplegia,3,16534124
0,22.0,Fatigue,1,16534129
1,22.0,Neuropathy peripheral,1,16534129
2,22.0,Vascular device infection,1,16534129
3,22.0,Neurodermatitis,1,16534129
4,22.0,Vascular device infection,1,16534129
5,22.0,Diarrhoea,1,16534129
6,22.0,Dyspnoea,1,16534129
0,22.0,Platelet count decreased,5,16534131
1,22.0,Ileus,5,16534131
2,22.0,Metastasis,5,16534131
0,22.0,Pleurisy,3,16534133
1,22.0,Radiation pneumonitis,3,16534133
2,22.0,Hepatic function abnormal,1,16534133
0,22.0,Paralysis,1,16534152
0,22.0,Prostate cancer metastatic,,16534160
0,22.0,Pleural effusion,5,16534162
1,22.0,Malignant neoplasm progression,5,16534162
2,22.0,Cerebrovascular accident,5,16534162
3,22.0,Respiratory failure,5,16534162
4,22.0,Metastases to meninges,5,16534162
5,22.0,Cerebral infarction,5,16534162
6,22.0,Pneumonia,5,16534162
0,22.0,Diarrhoea,6,16534169
0,22.0,Death,,16534170
0,22.0,Vomiting,1,16534173
1,22.0,Neutrophil count decreased,1,16534173
0,22.0,Thrombocytopenia,1,16534206
1,22.0,Disseminated intravascular coagulation,1,16534206
2,22.0,Neoplasm progression,6,16534206
0,22.0,Pneumonitis,1,16534214
1,22.0,Pneumonia,6,16534214
0,22.0,Bladder cancer,6,16534224
1,22.0,Product availability issue,6,16534224
2,22.0,Procedural pain,6,16534224
0,22.0,Disease progression,6,16534228
0,22.0,Pneumonia,5,16534236
0,22.0,Urticaria,6,16534240
0,22.0,Disease progression,6,16534258
0,22.0,Prostate cancer,6,16534267
1,22.0,Convalescent,6,16534267
2,22.0,Cataract,2,16534267
0,22.0,Respiratory distress,1,16534328
1,22.0,Anaphylactic reaction,1,16534328
2,22.0,Flushing,1,16534328
0,22.0,Wrong product administered,6,16534368
0,22.0,Arthralgia,2,16534392
0,22.0,Prostate cancer,5,16534400
1,22.0,Hospitalisation,3,16534400
2,22.0,Malaise,6,16534400
0,22.0,Disease progression,6,16534404
0,22.0,Disease progression,6,16534410
0,22.0,Disease progression,6,16534415
0,22.0,Disease progression,6,16534420
0,22.1,Pain,1,16534424
1,22.1,C-reactive protein increased,2,16534424
2,22.1,Oedema peripheral,1,16534424
3,22.1,Fall,1,16534424
4,22.1,Rash pruritic,2,16534424
5,22.1,Cardiac disorder,5,16534424
6,22.1,Photosensitivity reaction,5,16534424
7,22.1,General physical health deterioration,6,16534424
8,22.1,Seizure,1,16534424
9,22.1,Vitamin D deficiency,3,16534424
10,22.1,Calcium deficiency,3,16534424
11,22.1,Diabetes mellitus,1,16534424
12,22.1,Calcium deficiency,1,16534424
13,22.1,Hypokalaemia,3,16534424
14,22.1,Decubitus ulcer,3,16534424
0,22.0,Disease progression,6,16534425
0,22.0,Off label use,6,16534426
1,22.0,Gastric haemorrhage,6,16534426
0,22.0,Disease progression,6,16534427
0,22.0,Fistula of small intestine,6,16534429
1,22.0,Off label use,6,16534429
2,22.0,Sepsis,6,16534429
3,22.0,Respiratory failure,6,16534429
4,22.0,Peritonitis,6,16534429
0,22.0,Disease progression,6,16534432
0,22.0,Rib fracture,6,16534470
1,22.0,Metastases to spine,6,16534470
2,22.0,Metastases to liver,6,16534470
3,22.0,Gastrointestinal toxicity,6,16534470
4,22.0,Metastases to bone,6,16534470
5,22.0,Metastases to central nervous system,6,16534470
0,22.1,Neutropenia,1,16534472
1,22.1,Febrile neutropenia,1,16534472
2,22.1,Agranulocytosis,1,16534472
0,22.0,Bacteraemia,6,16534483
1,22.0,Embolism,6,16534483
2,22.0,Small intestinal obstruction,6,16534483
3,22.0,Liver function test abnormal,6,16534483
4,22.0,Urinary tract infection,6,16534483
5,22.0,Urinary retention,6,16534483
6,22.0,Neuropathy peripheral,6,16534483
7,22.0,Cardiac failure,6,16534483
8,22.0,Large intestine perforation,6,16534483
9,22.0,Off label use,6,16534483
10,22.0,Hypertension,6,16534483
0,22.0,Transaminases increased,1,16534496
0,22.0,Inflammation,3,16534508
1,22.0,Bone marrow failure,3,16534508
2,22.0,Diarrhoea,3,16534508
3,22.0,Acute respiratory distress syndrome,3,16534508
4,22.0,General physical health deterioration,3,16534508
5,22.0,Lung infiltration,3,16534508
6,22.0,Depressed level of consciousness,3,16534508
7,22.0,Respiratory failure,3,16534508
8,22.0,Cardiac failure,3,16534508
9,22.0,Stomatitis,3,16534508
10,22.0,Blood pressure decreased,3,16534508
11,22.0,Toxicity to various agents,3,16534508
0,22.0,Pancytopenia,3,16534513
1,22.0,Febrile neutropenia,3,16534513
0,22.0,Oesophageal neoplasm,6,16534531
1,22.0,Cough,6,16534531
2,22.0,Lip swelling,6,16534531
3,22.0,Fatigue,6,16534531
4,22.0,Meningioma,6,16534531
5,22.0,Dysphagia,6,16534531
6,22.0,Constipation,6,16534531
7,22.0,Headache,6,16534531
0,22.0,Disease progression,6,16534550
0,22.0,Disease progression,6,16534560
0,22.0,Disease progression,6,16534568
0,22.0,Disease progression,6,16534578
0,22.0,Disease progression,6,16534587
0,22.0,Intestinal perforation,5,16534599
1,22.0,Condition aggravated,5,16534599
2,22.0,Peritonitis,5,16534599
0,22.0,Diarrhoea,6,16534654
1,22.0,Guillain-Barre syndrome,5,16534654
2,22.0,Malignant neoplasm progression,6,16534654
3,22.0,Campylobacter infection,6,16534654
4,22.0,Asthenia,6,16534654
5,22.0,Palmar-plantar erythrodysaesthesia syndrome,6,16534654
6,22.0,Stomatitis,,16534654
0,22.0,Anaemia,2,16534691
1,22.0,Thrombocytopenia,2,16534691
2,22.0,Leukocytosis,2,16534691
0,22.0,Myocardial rupture,6,16534692
1,22.0,Torsade de pointes,6,16534692
2,22.0,Long QT syndrome,6,16534692
0,22.0,Febrile neutropenia,5,16534694
1,22.0,Renal failure,5,16534694
2,22.0,Bone marrow failure,5,16534694
0,22.0,Reflux gastritis,1,16534696
1,22.0,Nausea,1,16534696
2,22.0,Constipation,1,16534696
0,22.0,Haematochezia,1,16534713
0,22.0,Sequestrectomy,1,16534720
1,22.0,Mouth swelling,6,16534720
2,22.0,Pain in jaw,6,16534720
3,22.0,Oral mucosal erythema,6,16534720
4,22.0,Osteonecrosis of jaw,1,16534720
5,22.0,Off label use,6,16534720
0,22.0,Acute kidney injury,2,16534735
0,22.0,Pulmonary congestion,6,16534742
0,22.0,Phlebitis,6,16534777
1,22.0,Pulmonary embolism,6,16534777
0,22.0,Nasal septum perforation,6,16534792
1,22.0,Neutropenia,6,16534792
2,22.0,Dyspnoea,6,16534792
3,22.0,Deep vein thrombosis,6,16534792
4,22.0,Therapy partial responder,6,16534792
5,22.0,Skin toxicity,6,16534792
6,22.0,Stomatitis,6,16534792
7,22.0,Wheezing,6,16534792
8,22.0,Adenocarcinoma of colon,6,16534792
9,22.0,Anaemia,6,16534792
10,22.0,Rash,6,16534792
0,22.0,Colon cancer,2,16534806
1,22.0,Chills,2,16534806
2,22.0,Pyrexia,2,16534806
3,22.0,Haemoglobin decreased,2,16534806
0,22.0,Scratch,6,16534898
1,22.0,Rash pruritic,3,16534898
0,22.1,Metastases to lymph nodes,1,16534919
1,22.1,Musculoskeletal pain,1,16534919
0,22.0,Appendicitis,1,16534939
1,22.0,Intra-abdominal haemorrhage,1,16534939
2,22.0,Off label use,6,16534939
3,22.0,Intentional product use issue,6,16534939
0,22.1,Muscle rigidity,2,16534945
1,22.1,Pain,2,16534945
0,22.0,Ejection fraction decreased,6,16534946
0,22.0,Neutropenia,6,16534948
1,22.0,Polyneuropathy,6,16534948
2,22.0,Asthenia,6,16534948
3,22.0,Diarrhoea,6,16534948
4,22.0,Rash,6,16534948
0,22.0,Interstitial lung disease,1,16534955
0,22.0,Product dose omission,6,16535033
1,22.0,Off label use,6,16535033
2,22.0,Constipation,6,16535033
3,22.0,Product use in unapproved indication,6,16535033
0,22.0,Product administration error,6,16535037
0,22.0,Injection site haemorrhage,6,16535040
1,22.0,Injection site bruising,6,16535040
2,22.0,Energy increased,6,16535040
0,22.0,Injection site rash,1,16535043
0,22.0,Off label use,6,16535044
1,22.0,Oestradiol increased,6,16535044
0,22.0,Off label use,6,16535045
1,22.0,Product quality issue,6,16535045
0,22.0,Injection site pain,1,16535046
1,22.0,Product quality issue,6,16535046
2,22.0,Product administration error,6,16535046
0,22.0,Incorrect dose administered,6,16535057
1,22.0,Off label use,6,16535057
0,22.0,Off label use,6,16535060
0,22.0,Product dose omission,6,16535062
1,22.0,Product quality issue,6,16535062
2,22.0,Injection site pain,6,16535062
0,22.0,Fatigue,6,16535064
1,22.0,Injection site bruising,6,16535064
2,22.0,Pain,6,16535064
3,22.0,Thyroid disorder,6,16535064
4,22.0,Vulvovaginal burning sensation,6,16535064
5,22.0,Weight increased,6,16535064
6,22.0,Visual impairment,6,16535064
7,22.0,Vaginal disorder,6,16535064
0,22.0,Injection site bruising,6,16535067
0,22.0,Product dose omission,6,16535069
1,22.0,Product administration error,6,16535069
2,22.0,Off label use,6,16535069
0,22.0,Product quality issue,6,16535071
1,22.0,Product dose omission,1,16535071
0,22.0,Bone marrow failure,6,16535144
1,22.0,Liver injury,6,16535144
0,22.0,Decreased appetite,3,16535153
1,22.0,Chronic obstructive pulmonary disease,3,16535153
2,22.0,Headache,3,16535153
3,22.0,Weight decreased,3,16535153
4,22.0,Epilepsy,1,16535153
5,22.0,Contusion,3,16535153
0,22.0,Nail disorder,6,16535204
1,22.0,Musculoskeletal stiffness,6,16535204
2,22.0,Joint effusion,6,16535204
3,22.0,Arthralgia,6,16535204
4,22.0,Dactylitis,6,16535204
5,22.0,Product use in unapproved indication,6,16535204
6,22.0,Psoriasis,6,16535204
7,22.0,Red blood cell sedimentation rate increased,6,16535204
8,22.0,Myalgia,6,16535204
0,22.0,Extravasation,2,16535208
0,22.0,Blood pressure increased,1,16535215
1,22.0,Urinary tract infection,1,16535215
2,22.0,Fatigue,3,16535215
3,22.0,Muscle spasms,6,16535215
4,22.0,Arthralgia,3,16535215
5,22.0,Anaemia,6,16535215
6,22.0,Nephrolithiasis,1,16535215
7,22.0,Eastern Cooperative Oncology Group performance status worsened,6,16535215
8,22.0,Sciatica,3,16535215
9,22.0,Dyspnoea exertional,3,16535215
10,22.0,Constipation,2,16535215
11,22.0,Blood pressure decreased,6,16535215
12,22.0,Sinusitis,3,16535215
13,22.0,Nausea,2,16535215
14,22.0,Neuropathy peripheral,3,16535215
15,22.0,Emotional distress,6,16535215
16,22.0,Thrombocytopenia,6,16535215
17,22.0,Back pain,6,16535215
18,22.0,Swelling,3,16535215
19,22.0,Feeding disorder,2,16535215
0,22.0,Disease progression,6,16535222
0,22.1,Blood alkaline phosphatase increased,6,16535302
1,22.1,Blood bilirubin increased,6,16535302
2,22.1,Drug-induced liver injury,1,16535302
3,22.1,Hepatic steatosis,6,16535302
4,22.1,Cholelithiasis,6,16535302
5,22.1,Hepatic enzyme increased,1,16535302
6,22.1,Nasopharyngitis,1,16535302
7,22.1,Concomitant disease aggravated,6,16535302
8,22.1,Ascites,6,16535302
9,22.1,Transaminases increased,6,16535302
10,22.1,Inguinal hernia,1,16535302
11,22.1,Liver function test abnormal,1,16535302
0,22.0,Intentional product use issue,6,16535352
1,22.0,Death,5,16535352
2,22.0,Off label use,6,16535352
0,22.0,Malaise,6,16535354
1,22.0,Nail discomfort,3,16535354
2,22.0,Weight decreased,6,16535354
3,22.0,Nail disorder,6,16535354
4,22.0,Hair growth rate abnormal,3,16535354
0,22.1,Phlebitis,3,16535379
1,22.1,Deep vein thrombosis,3,16535379
2,22.1,Pelvic venous thrombosis,3,16535379
0,22.0,Pharyngeal necrosis,3,16535384
0,22.0,Muscular weakness,1,16535395
1,22.0,Hypoaesthesia,6,16535395
2,22.0,Muscle spasms,1,16535395
3,22.0,Dizziness,6,16535395
0,22.0,Colitis ulcerative,6,16535396
1,22.0,Product substitution issue,6,16535396
0,22.0,Lung infection,3,16535418
0,22.0,Death,5,16535423
0,22.1,Bone marrow failure,2,16535454
1,22.1,Dry throat,6,16535454
2,22.1,Bone pain,6,16535454
3,22.1,Dry mouth,6,16535454
4,22.1,Red blood cell count decreased,3,16535454
5,22.1,Myalgia,2,16535454
6,22.1,Platelet count decreased,1,16535454
7,22.1,Body temperature decreased,6,16535454
8,22.1,Rhinorrhoea,3,16535454
9,22.1,Blood potassium decreased,6,16535454
10,22.1,Cough,3,16535454
11,22.1,Taste disorder,6,16535454
12,22.1,Heart rate increased,6,16535454
13,22.1,Fatigue,3,16535454
14,22.1,Insomnia,3,16535454
15,22.1,White blood cell count decreased,1,16535454
16,22.1,Respiratory tract congestion,6,16535454
17,22.1,Oropharyngeal pain,6,16535454
18,22.1,Constipation,3,16535454
19,22.1,Arthralgia,3,16535454
0,22.1,Hypoacusis,6,16535482
1,22.1,Eating disorder,6,16535482
2,22.1,Memory impairment,6,16535482
3,22.1,Stress,6,16535482
4,22.1,Visual impairment,6,16535482
5,22.1,Neoplasm progression,6,16535482
6,22.1,Feeling abnormal,6,16535482
7,22.1,Cataract,6,16535482
8,22.1,Cognitive disorder,6,16535482
9,22.1,Tremor,6,16535482
10,22.1,Insomnia,6,16535482
0,22.1,Suicidal ideation,6,16535492
1,22.1,Neoplasm progression,1,16535492
2,22.1,Weight increased,1,16535492
3,22.1,Palpitations,2,16535492
4,22.1,Heart rate irregular,6,16535492
5,22.1,Heart rate increased,1,16535492
6,22.1,Fatigue,1,16535492
7,22.1,Asthenia,3,16535492
8,22.1,Arthralgia,6,16535492
9,22.1,Extrasystoles,2,16535492
10,22.1,Dyspepsia,1,16535492
11,22.1,Gait disturbance,1,16535492
12,22.1,White blood cell count decreased,1,16535492
13,22.1,Visual impairment,1,16535492
14,22.1,Dizziness,1,16535492
15,22.1,Dyspnoea,1,16535492
0,22.1,Memory impairment,6,16535517
0,22.1,Neoplasm progression,6,16535541
0,22.0,Neoplasm progression,6,16535580
0,22.1,Cholangitis sclerosing,2,16535581
0,22.0,White blood cell count decreased,6,16535598
1,22.0,Platelet count decreased,6,16535598
0,22.0,Full blood count decreased,6,16535607
0,22.0,Malaise,6,16535609
0,22.0,Arthralgia,6,16535612
1,22.0,Pain,6,16535612
2,22.0,Back pain,6,16535612
0,22.0,Product use issue,6,16535613
1,22.0,Off label use,6,16535613
0,22.0,Death,5,16535626
0,22.0,Jaw disorder,6,16535658
0,22.0,Hair texture abnormal,3,16535694
1,22.0,Hair colour changes,3,16535694
2,22.0,Hair disorder,3,16535694
3,22.0,Madarosis,3,16535694
4,22.0,Alopecia,3,16535694
0,22.0,Alopecia,3,16535695
1,22.0,Hair colour changes,3,16535695
2,22.0,Hair texture abnormal,3,16535695
3,22.0,Depression,6,16535695
4,22.0,Madarosis,3,16535695
5,22.0,Hair disorder,3,16535695
6,22.0,Anxiety,6,16535695
0,22.0,Hypertransaminasaemia,6,16535703
0,22.0,Intentional product use issue,6,16535712
1,22.0,Malignant neoplasm progression,5,16535712
0,22.0,White blood cell count decreased,6,16535747
1,22.0,Gastric disorder,6,16535747
2,22.0,Sinusitis,3,16535747
3,22.0,Dry eye,6,16535747
4,22.0,Dry throat,6,16535747
5,22.0,Arrhythmia,2,16535747
0,22.0,Haemolytic anaemia,2,16535756
1,22.0,Somnolence,6,16535756
0,22.0,Febrile neutropenia,5,16535769
0,22.0,Gastrointestinal anastomotic complication,6,16535776
1,22.0,Myocardial infarction,6,16535776
2,22.0,Off label use,6,16535776
0,22.0,Diplopia,6,16535780
0,22.0,Myositis,2,16535781
0,22.0,Visceral leishmaniasis,1,16535789
0,22.0,Deep vein thrombosis,6,16535794
1,22.0,Neuropathy peripheral,6,16535794
2,22.0,Condition aggravated,6,16535794
0,22.1,Prostate cancer,5,16535808
1,22.1,Anxiety,6,16535808
2,22.1,Insomnia,6,16535808
3,22.1,Product administration error,6,16535808
4,22.1,Myalgia,6,16535808
5,22.1,Muscular weakness,6,16535808
6,22.1,Paraesthesia,6,16535808
7,22.1,Terminal state,6,16535808
8,22.1,Panic attack,6,16535808
9,22.1,Depression,6,16535808
10,22.1,Asphyxia,6,16535808
11,22.1,Fear,6,16535808
12,22.1,Injury,6,16535808
13,22.1,Arthralgia,6,16535808
14,22.1,Burning sensation,6,16535808
15,22.1,Rheumatoid arthritis,6,16535808
16,22.1,Pyrexia,6,16535808
17,22.1,Erectile dysfunction,6,16535808
18,22.1,Hot flush,6,16535808
19,22.1,Dysuria,6,16535808
20,22.1,Lower respiratory tract infection,6,16535808
21,22.1,Vomiting,6,16535808
22,22.1,Bladder disorder,6,16535808
23,22.1,Osteoporosis,6,16535808
24,22.1,Feeling of body temperature change,6,16535808
25,22.1,Fatigue,6,16535808
26,22.1,Shock,6,16535808
27,22.1,Temperature regulation disorder,6,16535808
28,22.1,Malaise,6,16535808
29,22.1,Decreased appetite,6,16535808
30,22.1,Immobile,6,16535808
31,22.1,Blood disorder,6,16535808
0,22.0,Anaemia,6,16535817
1,22.0,Terminal state,6,16535817
2,22.0,Gait disturbance,6,16535817
3,22.0,Asthenia,6,16535817
0,22.0,Lung disorder,6,16535823
0,22.0,Agranulocytosis,1,16535858
1,22.0,Large intestine infection,1,16535858
0,22.0,Blood urine present,2,16535880
0,22.1,Weight decreased,6,16535885
1,22.1,Renal cancer metastatic,5,16535885
2,22.1,Pyrexia,1,16535885
3,22.1,Arrhythmia,1,16535885
4,22.1,Vomiting,2,16535885
5,22.1,Anxiety,2,16535885
6,22.1,Decreased appetite,6,16535885
7,22.1,Spinal pain,3,16535885
8,22.1,Anaemia,4,16535885
9,22.1,Nausea,2,16535885
10,22.1,Malignant neoplasm progression,5,16535885
11,22.1,Neck pain,6,16535885
12,22.1,Fatigue,6,16535885
0,22.0,Lung disorder,1,16535887
0,22.1,Diarrhoea,3,16535892
1,22.1,Metastases to lymph nodes,3,16535892
2,22.1,Invasive lobular breast carcinoma,3,16535892
3,22.1,Weight decreased,3,16535892
4,22.1,Cough,3,16535892
5,22.1,Malignant neoplasm progression,3,16535892
6,22.1,Breast cancer metastatic,3,16535892
7,22.1,Dysphonia,3,16535892
8,22.1,Lymphadenopathy,3,16535892
9,22.1,Osteoporosis,3,16535892
10,22.1,Concomitant disease aggravated,3,16535892
0,22.0,Malignant neoplasm progression,6,16535902
1,22.0,Drug resistance,6,16535902
0,22.1,Seizure,5,16535905
1,22.1,Tachycardia,6,16535905
2,22.1,Status epilepticus,6,16535905
3,22.1,Haemorrhage intracranial,6,16535905
4,22.1,Metastases to central nervous system,5,16535905
5,22.1,Metastases to lung,5,16535905
6,22.1,Skin lesion,2,16535905
7,22.1,Fatigue,3,16535905
8,22.1,Hypomagnesaemia,3,16535905
9,22.1,Hypotension,6,16535905
10,22.1,Renal cancer metastatic,5,16535905
11,22.1,Metastasis,5,16535905
12,22.1,Rash macular,6,16535905
13,22.1,Decreased appetite,3,16535905
14,22.1,Weight decreased,3,16535905
15,22.1,Hypercapnia,5,16535905
16,22.1,Malignant neoplasm progression,5,16535905
17,22.1,Skin toxicity,2,16535905
18,22.1,Hyperkeratosis,2,16535905
19,22.1,Haemorrhage,2,16535905
20,22.1,Facial paralysis,6,16535905
21,22.1,Altered state of consciousness,6,16535905
22,22.1,Eye disorder,6,16535905
0,22.0,Urinary tract infection bacterial,1,16535924
0,22.0,Death,5,16535931
0,22.1,Diplopia,2,16535950
1,22.1,Myasthenia gravis,2,16535950
2,22.1,Eyelid ptosis,2,16535950
3,22.1,Immune-mediated pancreatitis,2,16535950
0,22.0,Fall,6,16535951
1,22.0,Loss of consciousness,6,16535951
2,22.0,Suture insertion,6,16535951
3,22.0,Feeling abnormal,1,16535951
0,22.0,Breast cancer metastatic,6,16535990
1,22.0,Malignant neoplasm progression,6,16535990
2,22.0,Breast cancer stage IV,6,16535990
0,22.0,Diabetes mellitus,3,16536004
0,22.0,Asthenia,6,16536043
1,22.0,Decreased appetite,6,16536043
2,22.0,White blood cell count decreased,6,16536043
3,22.0,Fatigue,6,16536043
4,22.0,Dizziness,6,16536043
0,22.1,Neoplasm recurrence,6,16536046
0,22.0,White blood cell count decreased,3,16536052
1,22.0,Red blood cell count decreased,3,16536052
2,22.0,Product dose omission,1,16536052
0,22.0,Lung infection,1,16536109
0,22.1,Fatigue,6,16536110
1,22.1,Alopecia,6,16536110
2,22.1,Stomatitis,6,16536110
0,22.0,Neutropenia,6,16536114
1,22.0,Fatigue,6,16536114
2,22.0,Malaise,6,16536114
3,22.0,Walking disability,6,16536114
0,22.0,Death,5,16536138
0,22.0,Neoplasm progression,6,16536144
0,22.0,Dysphagia,6,16536175
0,22.0,Arthralgia,6,16536177
0,22.1,Alopecia,3,16536211
0,22.0,Blood pressure fluctuation,1,16536220
1,22.0,Arthritis,6,16536220
0,22.1,Hypoacusis,3,16536225
0,22.0,Neoplasm progression,6,16536234
1,22.0,Viral infection,6,16536234
0,22.1,White blood cell count decreased,6,16536244
1,22.1,Neoplasm progression,6,16536244
0,22.0,Extra dose administered,6,16536254
1,22.0,Back pain,6,16536254
0,22.0,Nausea,6,16536269
1,22.0,Blood phosphorus decreased,6,16536269
0,22.0,Diarrhoea,3,16536275
1,22.0,Abdominal discomfort,3,16536275
2,22.0,Death,5,16536275
3,22.0,Vomiting,3,16536275
0,22.1,Vomiting,6,16536296
1,22.1,Disturbance in attention,6,16536296
2,22.1,Tongue disorder,6,16536296
3,22.1,Product dose omission,6,16536296
4,22.1,Malaise,6,16536296
0,22.1,Neoplasm progression,5,16536303
1,22.1,Acute respiratory failure,5,16536303
0,22.0,Dry mouth,6,16536328
0,22.0,Tumour marker increased,6,16536329
1,22.0,Rubber sensitivity,6,16536329
2,22.0,Adverse event,6,16536329
0,22.0,Blood count abnormal,6,16536356
1,22.0,Therapy non-responder,6,16536356
2,22.0,Nasopharyngitis,6,16536356
0,22.0,Transfusion,6,16536364
1,22.0,Duodenal ulcer,6,16536364
2,22.0,Haemoglobin abnormal,6,16536364
0,22.0,Haematotoxicity,6,16536390
1,22.0,Neurotoxicity,6,16536390
0,22.0,Osteonecrosis of jaw,6,16536403
0,22.0,Osteonecrosis,3,16536410
1,22.0,Stress fracture,3,16536410
0,22.0,VIth nerve paralysis,6,16536412
0,22.0,Drug interaction,6,16536422
1,22.0,Hypoglycaemia,1,16536422
0,22.0,Gastrointestinal haemorrhage,1,16536424
1,22.0,Intentional product use issue,6,16536424
0,22.0,Dry skin,1,16536442
1,22.0,Dermatitis acneiform,1,16536442
2,22.0,Colon cancer stage IV,6,16536442
3,22.0,Pruritus,1,16536442
4,22.0,Disease progression,6,16536442
5,22.0,Paronychia,1,16536442
0,22.0,Malignant neoplasm progression,6,16536478
1,22.0,Lung abscess,1,16536478
2,22.0,Pneumonia,1,16536478
3,22.0,Pyrexia,1,16536478
4,22.0,Fungal infection,6,16536478
0,22.1,Neuropathy peripheral,3,16536479
1,22.1,Candida infection,3,16536479
2,22.1,Asthenia,3,16536479
3,22.1,Polyuria,3,16536479
4,22.1,Weight increased,3,16536479
5,22.1,Swelling,3,16536479
6,22.1,Dizziness,3,16536479
7,22.1,Vertigo,3,16536479
8,22.1,Ear pain,3,16536479
9,22.1,Abdominal tenderness,3,16536479
10,22.1,Urine output decreased,3,16536479
11,22.1,Lip dry,3,16536479
12,22.1,Muscle atrophy,3,16536479
13,22.1,Eye pruritus,6,16536479
14,22.1,Metastases to lymph nodes,3,16536479
15,22.1,Taste disorder,3,16536479
16,22.1,Muscle tone disorder,3,16536479
17,22.1,Chest pain,3,16536479
18,22.1,Dyspepsia,6,16536479
19,22.1,Somnolence,3,16536479
20,22.1,Micturition disorder,6,16536479
21,22.1,Depressed mood,3,16536479
22,22.1,Contusion,3,16536479
23,22.1,Urine odour abnormal,3,16536479
24,22.1,Gastrointestinal disorder,3,16536479
25,22.1,Disturbance in sexual arousal,3,16536479
26,22.1,Neck pain,3,16536479
27,22.1,Arthritis,3,16536479
28,22.1,Syncope,3,16536479
29,22.1,Affective disorder,3,16536479
30,22.1,Constipation,3,16536479
31,22.1,Fluid retention,3,16536479
32,22.1,Crying,3,16536479
33,22.1,Seasonal allergy,6,16536479
34,22.1,Weight fluctuation,3,16536479
35,22.1,Sinusitis,3,16536479
36,22.1,Fatigue,6,16536479
37,22.1,Sinus headache,6,16536479
38,22.1,Micturition urgency,6,16536479
39,22.1,Fatigue,3,16536479
40,22.1,Memory impairment,3,16536479
41,22.1,Flatulence,3,16536479
42,22.1,Nausea,3,16536479
43,22.1,Photosensitivity reaction,3,16536479
44,22.1,Tremor,3,16536479
45,22.1,Depression,6,16536479
46,22.1,Emotional disorder,3,16536479
47,22.1,Abdominal pain,3,16536479
48,22.1,Arthropathy,6,16536479
49,22.1,Bowel movement irregularity,3,16536479
50,22.1,Paraesthesia,3,16536479
51,22.1,Cough,3,16536479
52,22.1,Prostatomegaly,3,16536479
53,22.1,Pain,3,16536479
54,22.1,Mood swings,6,16536479
55,22.1,Weight decreased,3,16536479
56,22.1,Sinus disorder,3,16536479
57,22.1,Diarrhoea,3,16536479
58,22.1,Muscle mass,3,16536479
59,22.1,Thirst,3,16536479
60,22.1,Appetite disorder,3,16536479
61,22.1,Stress,6,16536479
62,22.1,Pyrexia,3,16536479
63,22.1,Headache,3,16536479
64,22.1,Dry skin,3,16536479
65,22.1,Feeling abnormal,3,16536479
66,22.1,Swelling face,3,16536479
67,22.1,Myalgia,3,16536479
68,22.1,Burning sensation,3,16536479
69,22.1,Aptyalism,3,16536479
70,22.1,Pollakiuria,3,16536479
71,22.1,Lymphadenitis,3,16536479
0,22.0,Neutropenia,6,16536520
1,22.0,Leukopenia,6,16536520
0,22.0,Hypotension,4,16536529
1,22.0,Atrial flutter,4,16536529
0,22.0,Respiratory failure,3,16536533
0,22.0,Glaucoma,6,16536534
1,22.0,Gastrooesophageal reflux disease,6,16536534
2,22.0,Pruritus,6,16536534
3,22.0,Chronic obstructive pulmonary disease,6,16536534
0,22.1,Hallucination,6,16536553
1,22.1,Drug intolerance,6,16536553
0,22.0,Drug interaction,2,16536571
1,22.0,Gastric ulcer haemorrhage,2,16536571
0,22.0,Leukopenia,6,16536609
1,22.0,Toxicity to various agents,6,16536609
0,22.1,Pain,2,16536632
1,22.1,Extravasation,2,16536632
0,22.1,Hyperbilirubinaemia,3,16536633
1,22.1,Anaemia,3,16536633
0,22.0,Gamma-glutamyltransferase increased,1,16536648
0,22.0,Drug interaction,6,16536665
1,22.0,Hypoglycaemia,1,16536665
0,22.0,Hypotension,6,16536666
1,22.0,Infusion related reaction,6,16536666
2,22.0,Malaise,6,16536666
3,22.0,Extrasystoles,6,16536666
0,22.1,Vomiting,1,16536700
1,22.1,Neuropathy peripheral,4,16536700
0,22.0,Liver injury,6,16536701
0,22.0,Disease progression,3,16536726
1,22.0,Colon cancer,3,16536726
0,22.0,Colon cancer,6,16536771
1,22.0,Disease progression,6,16536771
0,22.1,Liver disorder,1,16536797
1,22.1,Hepatic encephalopathy,6,16536797
2,22.1,Hepatic failure,5,16536797
3,22.1,Presyncope,1,16536797
0,22.0,Renal impairment,3,16536821
1,22.0,Feeling hot,1,16536821
2,22.0,Tinnitus,1,16536821
3,22.0,Vision blurred,1,16536821
4,22.0,Overdose,6,16536821
0,22.0,Malignant neoplasm progression,5,16536828
1,22.0,Organ failure,5,16536828
0,22.0,Metastases to central nervous system,6,16536829
1,22.0,Gait disturbance,6,16536829
2,22.0,Intervertebral disc protrusion,6,16536829
0,22.0,Cardiac failure,5,16536830
1,22.0,Malignant neoplasm progression,5,16536830
0,22.0,Drug resistance,6,16536873
1,22.0,Malignant neoplasm progression,6,16536873
2,22.0,Cough,6,16536873
0,22.0,Drug resistance,6,16536874
1,22.0,Malignant neoplasm progression,6,16536874
0,22.0,Malignant neoplasm progression,6,16536875
1,22.0,Drug resistance,6,16536875
0,22.0,Malignant neoplasm progression,6,16536888
1,22.0,Drug resistance,6,16536888
0,22.1,Neoplasm progression,6,16536948
1,22.1,Intestinal obstruction,6,16536948
0,22.0,Malignant neoplasm progression,6,16536952
1,22.0,Breast cancer,6,16536952
2,22.0,Malaise,6,16536952
3,22.0,Acute kidney injury,6,16536952
4,22.0,Dehydration,2,16536952
5,22.0,Diarrhoea,1,16536952
6,22.0,Mucosal inflammation,1,16536952
7,22.0,Discomfort,2,16536952
0,22.0,Bronchospasm,2,16536958
0,22.0,General physical health deterioration,1,16536966
1,22.0,Leukopenia,1,16536966
2,22.0,Nausea,1,16536966
3,22.0,General physical health deterioration,1,16536966
0,22.1,Decreased appetite,3,16536970
0,22.0,Abdominal distension,3,16536971
1,22.0,General physical health deterioration,3,16536971
2,22.0,Asthenia,3,16536971
0,22.0,Strangulated hernia,1,16536981
0,22.0,Acne,1,16537358
1,22.0,Diarrhoea,1,16537358
2,22.0,Weight increased,6,16537358
0,22.0,Malignant neoplasm progression,6,16537359
1,22.0,Metastases to central nervous system,6,16537359
2,22.0,Drug resistance,6,16537359
0,22.0,Drug resistance,6,16537368
1,22.0,Malignant neoplasm progression,6,16537368
0,22.0,Drug resistance,6,16537369
1,22.0,Malignant neoplasm progression,6,16537369
0,22.0,Drug resistance,6,16537370
1,22.0,Malignant neoplasm progression,6,16537370
0,22.0,Duodenal ulcer,3,16537377
0,22.0,Metastases to central nervous system,6,16537382
1,22.0,Malignant neoplasm progression,6,16537382
2,22.0,Drug resistance,6,16537382
0,22.0,Malignant neoplasm progression,6,16537383
1,22.0,Abdominal pain upper,6,16537383
2,22.0,Tumour pain,6,16537383
3,22.0,Drug resistance,6,16537383
4,22.0,Insomnia,6,16537383
5,22.0,Effusion,6,16537383
0,22.0,Erythema,3,16537384
1,22.0,Malignant neoplasm progression,6,16537384
2,22.0,Drug resistance,6,16537384
3,22.0,Skin exfoliation,3,16537384
0,22.0,Rash,6,16537420
1,22.0,Malignant neoplasm progression,6,16537420
2,22.0,Drug resistance,6,16537420
0,22.0,Hepatic lesion,6,16537436
1,22.0,Drug resistance,6,16537436
2,22.0,Malignant neoplasm progression,6,16537436
0,22.1,Malignant neoplasm progression,5,16537438
1,22.1,Interstitial lung disease,2,16537438
0,22.0,Fall,3,16537459
1,22.0,Weight decreased,3,16537459
2,22.0,Dizziness,3,16537459
3,22.0,Humerus fracture,3,16537459
0,22.0,Cardiac disorder,6,16537463
0,22.0,Malignant neoplasm progression,6,16537470
1,22.0,Drug resistance,6,16537470
0,22.0,Pruritus,6,16537599
1,22.0,Dry skin,6,16537599
2,22.0,Pelvic mass,6,16537599
3,22.0,Neurotoxicity,6,16537599
4,22.0,Hypomagnesaemia,6,16537599
5,22.0,Constipation,6,16537599
6,22.0,Adenocarcinoma of colon,6,16537599
7,22.0,Haematotoxicity,6,16537599
0,22.0,Drug resistance,6,16537609
1,22.0,Malignant neoplasm progression,6,16537609
0,22.0,Drug resistance,6,16537610
1,22.0,Malignant neoplasm progression,6,16537610
0,22.0,Drug resistance,6,16537613
1,22.0,Malignant neoplasm progression,6,16537613
0,22.0,Drug resistance,3,16537614
1,22.0,Malignant neoplasm progression,3,16537614
2,22.0,Drug ineffective,3,16537614
0,22.0,Pruritus,1,16537615
1,22.0,Malignant neoplasm progression,6,16537615
2,22.0,Neoplasm progression,6,16537615
3,22.0,Drug resistance,6,16537615
4,22.0,Diarrhoea,1,16537615
0,22.1,Prescribed underdose,6,16537616
1,22.1,Drug interaction,6,16537616
2,22.1,Haematuria,2,16537616
0,22.0,Malignant neoplasm progression,6,16537644
1,22.0,Drug resistance,6,16537644
0,22.0,Asthenia,6,16537666
1,22.0,Bladder neoplasm,6,16537666
0,22.0,Cerebrospinal fluid leakage,1,16537706
0,22.0,Drug resistance,6,16537710
1,22.0,Malignant neoplasm progression,6,16537710
0,22.0,Drug resistance,6,16537747
1,22.0,Malignant neoplasm progression,6,16537747
0,22.0,Metastases to bone,6,16537748
1,22.0,Drug resistance,6,16537748
2,22.0,Malignant neoplasm progression,6,16537748
0,22.0,Drug resistance,6,16537771
1,22.0,Malignant neoplasm progression,6,16537771
0,22.1,Skin swelling,3,16537777
1,22.1,Contusion,3,16537777
2,22.1,Dizziness,1,16537777
3,22.1,Constipation,3,16537777
0,22.0,Drug resistance,6,16537797
1,22.0,Malignant neoplasm progression,6,16537797
0,22.0,Drug resistance,6,16537798
1,22.0,Malignant neoplasm progression,6,16537798
0,22.0,Pyrexia,6,16537805
0,22.0,Drug resistance,6,16537806
1,22.0,Malignant neoplasm progression,6,16537806
0,22.0,Drug resistance,6,16537807
1,22.0,Malignant neoplasm progression,6,16537807
0,22.0,Type I hypersensitivity,1,16537812
0,22.0,Type I hypersensitivity,1,16537813
0,22.0,Type I hypersensitivity,1,16537821
0,22.0,Drug ineffective,6,16537824
0,22.0,Dyspnoea,5,16537834
1,22.0,Malignant neoplasm progression,6,16537834
2,22.0,Cardiac arrest,5,16537834
3,22.0,Cardiac failure,5,16537834
0,22.0,Malignant neoplasm progression,6,16537837
1,22.0,Drug resistance,6,16537837
0,22.0,Malignant neoplasm progression,6,16537838
1,22.0,Drug resistance,6,16537838
0,22.0,Malignant neoplasm progression,6,16537877
1,22.0,Drug resistance,6,16537877
0,22.0,Drug resistance,6,16537879
1,22.0,Malignant neoplasm progression,6,16537879
0,22.0,Bone marrow failure,3,16537895
0,22.0,Mitral valve incompetence,2,16537918
1,22.0,Left ventricular dysfunction,2,16537918
2,22.0,Bundle branch block left,2,16537918
3,22.0,Cardiotoxicity,2,16537918
4,22.0,Coronary artery disease,2,16537918
5,22.0,Cardiac failure chronic,2,16537918
6,22.0,Cardiac dysfunction,2,16537918
7,22.0,Congestive cardiomyopathy,2,16537918
0,22.0,Large intestine perforation,1,16537933
0,22.0,Psychological trauma,6,16538010
1,22.0,Alopecia,2,16538010
0,22.1,Emotional distress,6,16538095
1,22.1,Alopecia,2,16538095
2,22.1,Psychological trauma,6,16538095
0,22.0,Alopecia,3,16538137
1,22.0,Psychological trauma,6,16538137
0,22.0,Alopecia,2,16538147
0,22.0,Alopecia,2,16538151
1,22.0,Emotional distress,6,16538151
2,22.0,Pain,6,16538151
3,22.0,Anxiety,6,16538151
4,22.0,Psychological trauma,6,16538151
5,22.0,Impaired quality of life,6,16538151
0,22.0,Psychological trauma,6,16538154
1,22.0,Alopecia,2,16538154
0,22.0,Alopecia,2,16538182
0,22.0,Psychological trauma,6,16538215
1,22.0,Alopecia,2,16538215
0,22.0,Drug resistance,6,16538264
1,22.0,Malignant neoplasm progression,6,16538264
0,22.0,Delirium,1,16538302
1,22.0,Anxiety,6,16538302
2,22.0,Drug ineffective,3,16538302
0,22.0,Embolism venous,2,16538309
1,22.0,Neoplasm recurrence,6,16538309
0,22.0,Rash,6,16538311
1,22.0,Dyspnoea,6,16538311
2,22.0,Anaemia,6,16538311
3,22.0,Neutropenia,6,16538311
4,22.0,Wheezing,6,16538311
5,22.0,Stomatitis,6,16538311
6,22.0,Therapy partial responder,6,16538311
7,22.0,Skin toxicity,6,16538311
8,22.0,Nasal septum perforation,6,16538311
9,22.0,Deep vein thrombosis,6,16538311
10,22.0,Adenocarcinoma of colon,6,16538311
0,22.0,Enterocolitis,5,16538344
1,22.0,General physical health deterioration,6,16538344
2,22.0,Chest pain,6,16538344
3,22.0,Pericardial effusion,6,16538344
4,22.0,Malignant neoplasm progression,6,16538344
5,22.0,Underdose,6,16538344
6,22.0,Loss of consciousness,6,16538344
7,22.0,Anaemia,6,16538344
8,22.0,Pleural effusion,6,16538344
0,22.0,Death,5,16538353
0,22.0,Off label use,6,16538382
1,22.0,Disease progression,6,16538382
0,22.0,Anaemia,2,16538401
0,22.0,Drug resistance,6,16538426
1,22.0,Malignant neoplasm progression,6,16538426
0,22.0,Hydrocephalus,6,16538427
1,22.0,General physical health deterioration,6,16538427
2,22.0,Drug resistance,6,16538427
3,22.0,Speech disorder,3,16538427
4,22.0,Metastases to central nervous system,6,16538427
5,22.0,Pleural effusion,6,16538427
6,22.0,Malignant neoplasm progression,6,16538427
0,22.0,Hypersensitivity,6,16538433
1,22.0,Fatigue,6,16538433
2,22.0,Pancytopenia,6,16538433
3,22.0,Headache,6,16538433
4,22.0,Blood count abnormal,6,16538433
0,22.0,Death,5,16538478
0,22.0,Urticaria,1,16538491
1,22.0,Drug resistance,6,16538491
2,22.0,Malignant neoplasm progression,6,16538491
3,22.0,Diarrhoea,1,16538491
0,22.0,Malignant neoplasm progression,6,16538493
1,22.0,Drug resistance,6,16538493
0,22.0,Malignant neoplasm progression,6,16538494
1,22.0,Drug resistance,6,16538494
0,22.0,Malignant neoplasm progression,6,16538497
1,22.0,Drug resistance,6,16538497
0,22.0,Drug resistance,6,16538520
1,22.0,Malignant neoplasm progression,6,16538520
0,22.0,Drug resistance,6,16538522
1,22.0,Malignant neoplasm progression,6,16538522
0,22.0,Immune-mediated enterocolitis,2,16538564
0,22.0,Hepatic failure,3,16538566
0,22.0,Pulmonary fibrosis,5,16538577
0,22.1,Pulmonary fibrosis,5,16538579
0,22.0,Malignant neoplasm progression,6,16538584
1,22.0,Drug resistance,6,16538584
0,22.0,Drug resistance,6,16538585
1,22.0,Malignant neoplasm progression,6,16538585
0,22.0,Malignant neoplasm progression,6,16538586
1,22.0,Drug resistance,6,16538586
0,22.0,Malignant neoplasm progression,6,16538587
1,22.0,Drug resistance,6,16538587
0,22.0,Malignant neoplasm progression,6,16538591
0,22.0,Malignant neoplasm progression,6,16538594
1,22.0,Rash pustular,6,16538594
2,22.0,Drug resistance,6,16538594
0,22.0,Tendon rupture,4,16538595
0,22.0,Death,5,16538607
0,22.0,Vomiting,6,16538613
1,22.0,Myocardial ischaemia,6,16538613
2,22.0,Diarrhoea,6,16538613
0,22.0,Dry skin,6,16538620
1,22.0,Diarrhoea,6,16538620
2,22.0,Deep vein thrombosis,6,16538620
3,22.0,Erythema,6,16538620
0,22.0,Metastases to lymph nodes,6,16538639
1,22.0,Metastases to breast,6,16538639
2,22.0,Visual impairment,1,16538639
3,22.0,Vertigo,1,16538639
4,22.0,Neoplasm recurrence,3,16538639
0,22.0,Cardiac valve disease,6,16538640
1,22.0,Cardiac dysfunction,2,16538640
0,22.0,Lung disorder,6,16538641
1,22.0,Malignant neoplasm progression,6,16538641
0,22.0,Drug ineffective,6,16538642
1,22.0,Malignant neoplasm progression,3,16538642
2,22.0,Drug resistance,3,16538642
0,22.0,Malignant neoplasm progression,6,16538644
1,22.0,Drug resistance,6,16538644
0,22.0,Malignant neoplasm progression,5,16538648
1,22.0,Metastases to thorax,5,16538648
2,22.0,Drug resistance,6,16538648
0,22.0,Malignant neoplasm progression,6,16538649
1,22.0,Drug resistance,6,16538649
0,22.0,Malignant neoplasm progression,6,16538650
1,22.0,Drug resistance,6,16538650
0,22.0,Malignant neoplasm progression,6,16538651
1,22.0,Drug resistance,6,16538651
0,22.0,Malignant neoplasm progression,6,16538652
1,22.0,Drug resistance,6,16538652
0,22.0,Drug resistance,6,16538653
1,22.0,Malignant neoplasm progression,6,16538653
0,22.0,Drug resistance,6,16538654
1,22.0,Malignant neoplasm progression,6,16538654
0,22.0,Tumour haemorrhage,6,16538663
1,22.0,Tumour ulceration,2,16538663
0,22.0,Cardiac disorder,3,16538665
0,22.1,Anaemia,2,16538675
1,22.1,Aplasia pure red cell,1,16538675
0,22.1,Pancytopenia,2,16538712
1,22.1,Malignant neoplasm progression,6,16538712
0,22.0,Myopathy,2,16538714
0,22.0,Terminal state,6,16538752
0,22.0,Death,5,16538762
0,22.0,Nausea,1,16538780
1,22.0,Product substitution issue,6,16538780
2,22.0,Arrhythmia,1,16538780
0,22.0,Gastric cancer,6,16538782
0,22.0,Pain,6,16538784
1,22.0,Back pain,6,16538784
0,22.0,Terminal state,6,16538803
0,22.0,Off label use,6,16538830
1,22.0,Asthenia,3,16538830
2,22.0,General physical health deterioration,3,16538830
3,22.0,Abdominal distension,3,16538830
0,22.0,Platelet count decreased,1,16538846
1,22.0,Arteriovenous malformation,6,16538846
2,22.0,Thrombocytopenia,6,16538846
3,22.0,Anaemia,6,16538846
4,22.0,Chronic gastritis,6,16538846
0,22.0,Type I hypersensitivity,1,16538847
0,22.0,Pulmonary embolism,1,16538848
0,22.0,Type I hypersensitivity,1,16538851
0,22.0,Type I hypersensitivity,1,16538852
0,22.1,Extrapyramidal disorder,1,16538892
1,22.1,Tremor,1,16538892
2,22.1,Haematuria,1,16538892
0,22.0,Malignant neoplasm progression,6,16538900
1,22.0,Gastric stenosis,3,16538900
0,22.0,Ankle fracture,1,16538916
0,22.0,Erythema,1,16538926
1,22.0,Dyspnoea,1,16538926
0,22.0,Pneumonia,1,16538928
0,22.1,Pyrexia,1,16538929
1,22.1,Off label use,6,16538929
2,22.1,Diarrhoea infectious,1,16538929
0,22.0,Anaphylactic shock,1,16539019
0,22.0,Status epilepticus,1,16539020
1,22.0,Rhabdomyolysis,1,16539020
2,22.0,Acute respiratory failure,1,16539020
3,22.0,Endotracheal intubation,1,16539020
0,22.0,Death,,16539021
0,22.0,General physical health deterioration,5,16539034
0,22.0,Pneumonitis,3,16539050
0,22.0,Metastases to liver,5,16539068
1,22.0,Malignant neoplasm progression,5,16539068
2,22.0,Hepatic failure,5,16539068
0,22.0,Death,5,16539089
0,22.0,Abdominal pain upper,6,16539101
1,22.0,Chills,6,16539101
2,22.0,Night sweats,6,16539101
3,22.0,Dizziness,6,16539101
0,22.0,Type I hypersensitivity,1,16539141
0,22.0,Type I hypersensitivity,1,16539142
0,22.0,Adverse event,6,16539146
1,22.0,Product use in unapproved indication,6,16539146
0,22.1,Neoplasm progression,6,16539155
1,22.1,Loss of personal independence in daily activities,6,16539155
0,22.0,Disease progression,,16539164
0,22.0,Fatigue,6,16539187
1,22.0,Vomiting,6,16539187
2,22.0,Nausea,6,16539187
3,22.0,Diarrhoea,6,16539187
4,22.0,Mucosal inflammation,6,16539187
5,22.0,Cardiac failure congestive,6,16539187
6,22.0,Bone marrow failure,6,16539187
0,22.1,Neuropathy peripheral,6,16539216
1,22.1,Gastric leiomyoma,6,16539216
2,22.1,Carpal tunnel syndrome,6,16539216
3,22.1,Hypoacusis,6,16539216
0,22.0,Neoplasm progression,6,16539218
1,22.0,Second primary malignancy,6,16539218
2,22.0,Hepatic cancer,6,16539218
0,22.0,Malignant neoplasm progression,6,16539230
1,22.0,Bone cancer,6,16539230
2,22.0,Product use in unapproved indication,6,16539230
0,22.0,Death,5,16539241
0,22.1,Headache,2,16539256
1,22.1,Dyspnoea,2,16539256
2,22.1,Abdominal pain,2,16539256
3,22.1,Skin disorder,6,16539256
